Position in VTRS
as of Mar 31, 2026
· filed May 6, 2026
Position Value
$108,537,664
+$107,400,307 QoQ
Shares Held
8,033,876
+8694.2% QoQ
Ownership
0.690%
of shares outstanding
% of Portfolio
0.37%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2020
22 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in VTRS Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026Pacer Advisors, Inc. holds $370,550,834 across 18 Drug Manufacturers - Specialty & Generic names. VTRS ranks #2 (29.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | UTHR |
UNITED THERAPEUTICS Corp
|
243,545 | $144,417,314 | |
| 2 | VTRS |
Viatris Inc
This page
|
8,033,876 | $108,537,664 | |
| 3 | ALKS |
Alkermes plc.
|
688,563 | $24,347,587 | |
| 4 | NBIX |
Neurocrine Biosciences Inc
|
169,230 | $22,294,360 | |
| 5 | ZTS |
Zoetis Inc.
|
165,570 | $19,572,029 | |
| 6 | BCRX |
Biocryst Pharmaceuticals Inc
|
1,563,040 | $14,880,140 | |
| 7 | COLL |
Collegium Pharmaceutical, Inc
|
256,365 | $8,477,990 | |
| 8 | ANIP |
Ani Pharmaceuticals Inc
|
85,467 | $6,572,412 |
All Filings in VTRS
Export CSV
22 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $108,537,664 | 8,033,876 | Shares | Sole | 2026-05-06 | |
| 2025-12-31 | $1,137,357 | 91,354 | Shares | Sole | 2026-02-24 | |
| 2025-09-30 | $1,030,590 | 104,100 | Shares | Sole | 2025-10-15 | |
| 2025-06-30 | $83,561,072 | 9,357,343 | Shares | Sole | 2025-08-12 | |
| 2025-03-31 | $98,929,059 | 11,358,101 | Shares | Sole | 2025-05-06 | |
| 2024-12-31 | $437,656,119 | 35,153,102 | Shares | Sole | 2025-01-22 | |
| 2024-09-30 | $1,332,944 | 114,810 | Shares | Sole | 2024-11-12 | |
| 2024-06-30 | $407,251,393 | 38,311,514 | Shares | Sole | 2024-08-13 | |
| 2024-03-31 | $315,397,261 | 26,415,181 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $225,840,524 | 20,853,234 | Shares | Sole | 2024-01-16 | |
| 2023-09-30 | $154,447,454 | 15,664,042 | Shares | Sole | 2023-11-13 | |
| 2023-06-30 | $156,304,724 | 15,661,796 | Shares | Sole | 2023-07-12 | |
| 2023-03-31 | $139,670,019 | 14,518,713 | Shares | Sole | 2023-05-02 | |
| 2022-12-31 | $136,257,466 | 12,242,360 | Shares | Sole | 2023-02-06 | |
| 2022-09-30 | $79,559,189 | 9,337,933 | Shares | Sole | 2022-10-18 | |
| 2022-06-30 | $87,318,480 | 8,339,874 | Shares | Sole | 2022-08-12 | |
| 2022-03-31 | $52,477,786 | 4,823,326 | Shares | Sole | 2022-04-05 | |
| 2021-12-31 | $1,093,751 | 80,839 | Shares | Sole | 2022-02-03 | |
| 2021-09-30 | $1,546,326 | 114,120 | Shares | Sole | 2021-10-15 | |
| 2021-06-30 | $1,459,466 | 102,132 | Shares | Sole | 2021-07-21 | |
| 2021-03-31 | $947,263 | 67,807 | Shares | Sole | 2021-04-05 | |
| 2020-12-31 | $1,401,283 | 74,775 | Shares | Sole | 2021-01-20 | |
| No filing history on record for this holder in this stock. | ||||||